Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.489 USD | +4.49% | +2.01% | -87.30% |
04-08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
03-21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.30% | 5.31M | |
+11.97% | 116B | |
+13.11% | 106B | |
-9.71% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.20% | 16.33B | |
+6.49% | 14.14B | |
+30.27% | 12.02B |
- Stock Market
- Equities
- KA Stock
- News Kineta, Inc.
- Kineta Closes $3 Million Offering of Common Stock